The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy

Vaccine

Volumn 23, Issue 17-18, 2005, Pages 2354-2358

  Zanoni, G ^a   Ferro, A ^b   Valsecchi, M ^c   Tridente, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Regional Health Authority   (Italy)

^c Department of Health and Safety at Work (SPISAL)   (Italy)

Author keywords

Adverse events; Immunization; Surveillance

Indexed keywords

ACELLULAR VACCINE; BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TYPHOID VACCINE;

AFEBRILE CONVULSION; ANAPHYLACTOID PURPURA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTHRITIS; ASEPTIC MENINGITIS; ATAXIA; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; CONSULTATION; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; ERYTHROCYTE DISORDER; FACIAL NERVE PARALYSIS; FEVER; GASTROINTESTINAL DISEASE; GUILLAIN BARRE SYNDROME; GYNECOLOGIC DISEASE; HEARING DISORDER; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART RATE AND RHYTHM; HEPATITIS; HEPATOBILIARY DISEASE; HUMAN; HYPOTONIC HYPORESPONSIVE EPISODE; IMMUNOPATHOLOGY; INFANT DISEASE; INJECTION SITE REACTION; ITALY; LEUKOCYTE DISORDER; LIVER DISEASE; MAJOR CLINICAL STUDY; MENTAL DISEASE; METABOLIC DISORDER; MIGRAINE; MUSCULOSKELETAL DISEASE; MYELITIS; MYOPATHY; NEURITIS; NEUROLOGIC DISEASE; NEWBORN DISEASE; NUTRITIONAL DISORDER; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; PUBLIC HEALTH SERVICE; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SERUM SICKNESS; SIDE EFFECT; SKIN MANIFESTATION; SMELLING DISORDER; SPEECH DISORDER; STRABISMUS; TASTE DISORDER; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; THROMBOSIS; URINARY TRACT DISEASE; URTICARIA; VACCINATION; VASCULAR DISEASE; VASCULITIS; VERTIGO; VESTIBULAR DISORDER; VISUAL DISORDER;

EID: 14844320018     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.021     Document Type: Conference Paper

References (9)

1. E. Kurstak Towards the new global vaccinology era in prevention and control of diseases Vaccines 21 2003 580 581
2. R.T. Chen Vaccine risks: real, perceived and unknown Vaccine 17 1999 41 46
3. R.T. Chen, R.L. Davis, and K.M. Sheedy Safety of immunizations S.A. Plotkin W.A. Orestein Vaccines 2004 W.B. Saunders Philadelphia 1557 1581
4. G. Zanoni, T.M.D. Nguyen, M. Valsecchi, G. Gallo, and G. Tridente Prevention and monitoring of adverse events following immunization: the "Green Channel" of the Veneto region in Italy Vaccine 22 2003 194 201
5. C.G. Casey, S. Campbell, and J. Iskander Clinical assessment of adverse events following immunization (AEFIs): a converging new international paradigm? Pharmacoepidemiol Drug Saf 13 suppl. 2004 13 14
6. Immunization Safety Surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization. WPRO/EPI/99.01. Manila: WHO Regional Office for the Western Pacific; 1999.
7. E.J. Gangarosa, A.M. Galazka, and C.R. Wolfe Impact of anti-vaccine movements on pertussis control: the untold story Lancet 351 1998 356 361
8. R.T. Chen, F. De Stefano, and R.L. Davis The Vaccine safety datalink: immunization research in health maintenance organizations in the USA Bull World Health Organ 78 2000 186 194
9. R.M. Wolfe, L.K. Sharp, and M.S. Lipsky Content and design attributes of antivaccination web sites JAMA 287 2002 3245 3248